Practice guidelines for the management of adult community-acquired urinary tract infections

Caron, François; Galpérine, Tatiana; Flateau, C.; Azria, R.; Bonacorsi, Stéphane; Bruyère, F.; Cariou, G.; Clouqueur, É.; Cohen, Robert; Doco‐Lecompte, T.; Eléfant, Élisabeth; Faure, Karine; Gauzit, R.; Gavazzi, G.; Lemaître, L.; Raymond, Josette; Senneville, É.; Sotto, Albert; Subtil, D.; Trivalle, C.; Mérens, Audrey; Etienne, Manuel

doi:10.1016/j.medmal.2018.03.005

Cited by 140 publications

(151 citation statements)

References 63 publications

Supporting

Mentioning

137

Contrasting

Unclassified

Order By: Relevance

“…France [9], unlike the United Kingdom and the Netherlands [14,15]. PtDAs obtain credibility when they are developed simultaneously with national guidelines [23], as NICE has been able to do [24].…”

Section: Discussionmentioning

confidence: 99%

“…There were no reported cases of sepsis. The French guidelines describe the risk of pyelonephritis as very low [9].…”

Section: Risk Of Complicationsmentioning

confidence: 99%

“…The choice of the primary antibiotic often varies from one country to another [8]. In France, the French-language infectious pathology society (Société de pathologie infectieuse de langue française) recommends fosfomycin as the primary therapy [9]. The antibiotic prescribed empirically is often ill-adapted to the microbiological results [10].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Vincent

Frachon

BUFFETEAU

et al. 2020

Preprint

View full text Add to dashboard Cite

Background Uncomplicated urinary tract infection (uUTI) is a frequent reason for consulting a general practitioner. The risk of pyelonephritis is low. Antibiotics are prescribed empirically for symptomatic purposes. It can induce undesirable effects and resistance. Patients sometimes wish to avoid taking antibiotics. Some European countries recommend discussing a delayed prescription with the patient and developing a shared decision. The aim of our study is to develop a patient decision aid (PtDA) that can be used in primary care to make a shared decision about whether to treat uncomplicated urinary tract infection with antibiotics or not. Methods We followed the steps recommended by the International Patient Decision Aids Standards, which include a design phase (focus groups, bibliography) and an alpha-testing phase. A steering group developed a draft and then final version of a prototype PtDA. Results The information included in the PtDA is the definition of uUTI, information on the options, their benefits, risks and consequences. The patient's values and preferences to be considered in the decision are related to the discomfort felt, the impact on daily life, the representations of the antibiotic, the position relative to the risk of adverse effect. Conclusions Our results confirm a need for decision making and the equilibrium in this situation. We lacked advice from outside physicians in the study. This PtDA needs to be validated in a beta-testing phase. It must then be tested in a clinical study comparing its use with the systematic prescription approach.

show abstract

Section: Discussionmentioning

confidence: 99%

“…There were no reported cases of sepsis. The French guidelines describe the risk of pyelonephritis as very low [9].…”

Section: Risk Of Complicationsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Vincent

Frachon

BUFFETEAU

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…En cas de rétention associée avec nécessité de drainage des urines ou en présence de signes de sepsis grave, on passe dans le cadre de l'infection urinaire grave [15] nécessitant d'instaurer le traitement sous surveillance en hospitalisation.…”

Section: Prostatite Aiguëunclassified

Recommandations jointes des comités de l’AFU (neuro-urologie, CUROPF, CTMH) pour l’urologie fonctionnelle durant la crise sanitaire liée au COVID-19

Michel

Gaillet

Cornu

et al. 2020

Progrès en Urologie

View full text Add to dashboard Cite

“…First line antibiotic treatment often differs from one country to another [12]:in France, the Frenchlanguage infectious pathology society (Société de pathologie infectieuse de langue française) recommends fosfomycin [13], but it is important to note that, frequently, the antibiotic prescribed empirically does not match pathogen sensitivity on the microbiological results [14].The effectiveness of a systematic antibiotic strategy on the infection must be put into perspective with adverse effects like mycosis, headache, dizziness and digestive disorders, and with the risk of resistance emergence [15]. In France, uoroquinolones resistant E. Coli are found in 3% to 7% of UTI in primary care [16] [17].…”

Section: Introductionmentioning

confidence: 99%

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Vincent

Frachon

BUFFETEAU

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Uncomplicated urinary tract infection (uUTI) is a frequent disorder in general practice. The risk of developing pyelonephritis remains low after uUTI, nonetheless, empiric antibiotic therapy is frequently prescribed for symptomatic purposes. This can lead to adverse effects and antibiotic resistance. Furthermore, patients sometimes wish to avoid taking antibiotics. Some European countries recommend discussing a delayed prescription with the patient and developing a shared decision. The aim of our study is to develop a patient decision aid (PtDA) that can be used in primary care to make a shared decision about whether to treat uUTI with antibiotics or not.Methods: We followed the steps recommended by the International Patient Decision Aids Standards, with a scoping phase, a design phase (including focus groups and literature review),and an alpha-testing phase. A steering group, made up of patients and physicians, met throughout the study to develop a draft and then a final version of a prototype PtDA.Results: The information included in the PtDA is the definition of uUTI, information on the options, their benefits, risks, and consequences, based on a review of the literature. The results of the focus group made it possible to determine the patient's values and preferences to be considered in decision-making, namely: the discomfort felt, the impact on daily life, the representations of antibiotics, and the position relative to the risk of adverse effect. The choices of presentation, organisation and design are the result of the work of the steering group, improved by feedback from alpha testing.Conclusions: Our results confirm a need for shared decision-making and the equipoise in this situation. More advice from outside physicians is still lacking. This PtDA needs to be validated in a beta-testing phase, and then tested in a clinical study comparing its use with the systematic prescription approach.

show abstract

Practice guidelines for the management of adult community-acquired urinary tract infections

Cited by 140 publications

References 63 publications

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Recommandations jointes des comités de l’AFU (neuro-urologie, CUROPF, CTMH) pour l’urologie fonctionnelle durant la crise sanitaire liée au COVID-19

Construction of a patient decision aid for the treatment of uncomplicated urinary tract infection in primary care

Contact Info

Product

Resources

About